about
mission / vision
our team
board members
executive leadership
scientists
careers
postdoctoral programs
internship programs
current job opportunities
| |
Chris Hentschel
Chris Hentschel has served on IDRI’s Board of Directors since March of 2010. He is a Founder, former Chief Executive Officer, and Board member of the Medicines for Malaria Venture (MMV), a nonprofit Geneva-based Swiss Foundation. MMV operates as a public/private partnership which, with its pharmaceutical partners, funds and manages the World's largest portfolio of anti-malarial drug discovery and development projects. Prior to joining MMV, Chris acted as Senior Vice President and Chief Scientific Officer of Centocor, Inc. where he was responsible for all aspects of technology strategy and the development of the product pipeline. From 1978 to 1997, Chris was Chief Executive Officer and Scientific Director of the UK Medical Research Council's Collaborative Centre (now renamed MRC Technology), where he managed more than forty industrial drug discovery and development collaborations with both global pharma and biotechnology companies. Chris started his career at Celltech Ltd., Europe's largest biotechnology company, during the company’s start-up phase. He was Head of the Department of Molecular Genetics and helped set up the company’s R&D operations. Currently, Chris serves on the boards of the Global Medical Forum Foundation (GMF, Zurich) and MSM Protein technologies. He is also a partner of Life Science Ventures (LSV, Cayman Islands).
|
|
